411 filings
425
KTRA
Kintara Therapeutics Inc
14 May 24
Business combination disclosure
4:55pm
8-K
KTRA
Kintara Therapeutics Inc
14 May 24
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
4:50pm
10-Q
2024 Q3
KTRA
Kintara Therapeutics Inc
Quarterly report
14 May 24
4:40pm
S-4
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
8-K
KTRA
Kintara Therapeutics Inc
9 May 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:15pm
8-K
o6v252zvjxz c8f20
25 Apr 24
Regulation FD Disclosure
9:05am
425
c9g7 uzoqva7
25 Apr 24
Business combination disclosure
9:05am
425
xkvc64ozi098ur
3 Apr 24
Business combination disclosure
7:15am
8-K
1j15s1d
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
RW
k3nyyv ff5u
13 Mar 24
Registration withdrawal request
7:00am
8-K
2egkh2u
27 Feb 24
Other Events
6:59am
8-K
ebk8cq1g9njprsnby6d
26 Feb 24
Other Events
7:00am
8-K
x8vk6xoe8 9j
22 Feb 24
Other Events
7:00am
8-K
w9t5b5jakjjk4quanf97
14 Feb 24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
4:10pm
8-K
unjbpqy 8w
12 Feb 24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
9:05am
8-K
gapjsg1nobq5xs6lma3i
18 Dec 23
Other Events
4:10pm
424B5
uvpa4xrn
18 Dec 23
Prospectus supplement for primary offering
4:05pm
8-K
eopxwrpmy axqds9
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
1ts 17bv5stlf
7 Dec 23
Kintara Therapeutics Announces Review of Strategic Alternatives
9:10am